In CLL, the ligands Wnt5A and Wnt5B, which regulate the non-canonical Wnt/PCP pathway, and their effectors are overexpressed, and they regulate the communication of CLL cells with the microenvironment [10]. Here, WNT5B is linked to B-cell chronic lymphocytic leukemia.